Presence of human polyomavirus DNA in the peripheral circulation of bone marrow transplant patients with and without hemorrhagic cystitis.
In BMT patients, shedding of BK virus (BKV) in the urine has been strongly but not absolutely correlated to hemorrhagic cystitis (HC). The possible presence of human polyomaviruses in peripheral blood leukocytes (PBLs), plasma, serum and urine in BMT patients and an association with HC was investigated by a nested PCR assay. Samples from allogeneic BMT patients with and without HC as well as from autologous BMT patients were analyzed. Human polyomaviruses were detected in urine and blood samples of both allogeneic and autologous BMT patients with and without HC. An association between the presence of a specific human polyomavirus in blood and HC was thus not observed.
Bogdanovic
G
G
Institute for Immunology, Microbiology, Pathology and Infectious Diseases, Huddinge University Hospital, Sweden.
Ljungman
P
P
Wang
F
F
Dalianis
T
T
D000293:Adolescent; D000328:Adult; D001739:BK Virus / Q000254:growth & development / Q000302:isolation & purification* / Q000472:pathogenicity; D016026:Bone Marrow Transplantation; D003520:Cyclophosphamide / Q000009:adverse effects*; D003556:Cystitis / Q000209:etiology / Q000821:virology*; D004279:DNA, Viral / Q000097:blood / Q000302:isolation & purification* / Q000652:urine; D005260:Female; D006470:Hemorrhage / Q000209:etiology / Q000821:virology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007577:JC Virus / Q000254:growth & development / Q000302:isolation & purification* / Q000472:pathogenicity; D007938:Leukemia / Q000150:complications / Q000628:therapy*; D007948:Leukemia, Monocytic, Acute / Q000150:complications / Q000628:therapy; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000628:therapy; D008297:Male; D009190:Myelodysplastic Syndromes / Q000150:complications / Q000628:therapy; D016133:Polymerase Chain Reaction; D027601:Polyomavirus Infections / Q000150:complications / Q000821:virology*; D019172:Transplantation Conditioning / Q000009:adverse effects*; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D014412:Tumor Virus Infections / Q000150:complications / Q000821:virology*; D014556:Urine / Q000821:virology*; D014766:Viremia / Q000821:virology*; D014775:Virus Activation
D004279:DNA, Viral; D003520:Cyclophosphamide